Open AccessModelling preeclampsia: a comparative analysis of the common human trophoblast cell lines
Author(s) -
Zhao Jiawu,
Chow Rebecca P.,
McLeese Rebecca H.,
Hookham Michelle B.,
Lyons Timothy J.,
Yu Jeremy Y.
Publication year - 2021
Publication title -
faseb bioadvances
Language(s) - English
Resource type - Journals
ISSN - 2573-9832
DOI - 10.1096/fba.2020-00057
Subject(s) - trophoblast , hypoxia (environmental) , preeclampsia , umbilical vein , placenta , soluble fms like tyrosine kinase 1 , messenger rna , cell culture , biology , endocrinology , andrology , medicine , pharmacology , microbiology and biotechnology , chemistry , fetus , placental growth factor , gene , in vitro , biochemistry , genetics , pregnancy , oxygen , organic chemistry
ABSTRACT Preeclampsia remains a challenge without an effective therapy. Evidence supports targetability of soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and soluble endoglin (sEng), which are released excessively from the placenta under ischemic and hypoxic stresses. We compared four trophoblast cell lines, BeWo, Jar, Jeg‐3, and HTR‐8/SVneo, in order to identify a suitable model for drug screening. Cultured trophoblasts were exposed to 1% oxygen vs. normoxia for 24‐48 hr; human umbilical vein and aortic endothelial cells were included for comparison. Supernatant sFlt‐1 and sEng concentrations were measured by ELISA, and sFlt‐1 mRNA expression determined by RT‐PCR. Cellular responses to experimental therapeutics were explored. All four trophoblast lines secreted sEng, which did not increase by hypoxia. BeWo, Jar, and Jeg‐3 exhibited significantly enhanced expression of sFlt‐1 i13 and e15a mRNA in response to hypoxia; however, only BeWo released a detectable level of sFlt‐1 protein, which was doubled by hypoxia. In contrast, hypoxia decreased sFlt‐1 mRNA expression and protein release in HTR‐8/SVneo, similarly to endothelial cells. The cellular mechanism involved HIFα. BeWo responded to representative agents similarly to human primary placental tissues in the literature. These data support that the BeWo‐hypoxia model mimics a key pathogenic mechanism of preeclampsia and has potential value for translational drug discovery.